TL;DR
This study introduces and validates the NINDS-CSN 5-minute protocol as a rapid screening tool for cognitive impairment (CI) in Parkinson's Disease (PD) patients. It demonstrates that this brief protocol is as effective as the more time-consuming MoCA and significantly better than the MMSE, making it a practical option for busy clinical settings.
What Problem Does This Paper Address?
Parkinson's Disease (PD) is a progressive neurodegenerative disorder that frequently leads to cognitive impairment (CI). This CI significantly impacts patients' quality of life and increases caregiver burden. Early detection of CI is crucial for timely management and intervention. However, existing screening tools like the Montreal Cognitive Assessment (MoCA) can take up to 10 minutes to administer, which can be challenging in busy clinical environments, especially for PD patients who may experience speech and motor difficulties that prolong assessment time. The paper addresses the need for a rapid, yet accurate, cognitive screening tool specifically for PD patients.
Methods
The researchers evaluated the discriminant validity of the National Institute of Neurological Disease and Stroke-Canadian Stroke Network (NINDS-CSN) 5-minute protocol. This protocol is a subset of the MoCA, comprising only the 5-word recall, 6-item orientation, and verbal fluency components. They compared its performance against the full MoCA and the Mini Mental State Examination (MMSE) in detecting cognitive impairment in PD patients. The study recruited 101 PD patients and assessed them using all three instruments. Cognitive impairment was defined using the Clinical Dementia Rating (CDR) scale, with CDR=0 indicating no cognitive impairment (NCI) and CDR ≥ 0.5 indicating cognitive impairment (CI). Receiver Operating Characteristic (ROC) curve analyses were used to compare the diagnostic accuracy (sensitivity, specificity, and area under the curve) of the three screening tools.
Datasets
The study utilized data from 101 consecutive Parkinson's Disease patients recruited from a movement disorders clinic at the National University Hospital, Singapore. This constitutes the primary dataset for the evaluation of the screening tools. No new datasets were introduced.
Key Insights and Ideas
- The "subcortical profile" connection: The paper highlights that PD shares cognitive patterns (like bradyphrenia and frontal-executive deficits) with vascular cognitive impairment, for which the NINDS-CSN 5-minute protocol was initially developed. This shared profile suggests its potential utility in PD.
- Time is of the essence: The core motivation is the need for a quick screening tool. The NINDS-CSN 5-minute protocol's brevity is presented as a significant advantage over the MoCA, especially for PD patients who might have slower response times.
- MoCA's foundation is strong: The NINDS-CSN 5-minute protocol is derived from the MoCA, leveraging its established effectiveness. The study confirms that a significant portion of the MoCA's discriminatory power for PD CI can be captured by a few key components.
Key Results
The NINDS-CSN 5-minute protocol demonstrated strong performance in detecting cognitive impairment in PD patients:
- Area Under the Curve (AUC): The AUC for the NINDS-CSN 5-minute protocol (0.86) was statistically equivalent to the MoCA (0.90, P=0.07) and significantly larger than the MMSE (0.76, P=0.03).
- Sensitivity: The sensitivity of the NINDS-CSN 5-minute protocol (0.77) was statistically equivalent to the MoCA (0.85, P=0.13) and superior to the MMSE (0.52, P<0.01).
- Specificity: The specificity of the NINDS-CSN 5-minute protocol (0.78) was statistically equivalent to both the MoCA (0.88) and MMSE (0.88) (P=0.34 for both comparisons).
- Optimal Cut-off: The optimal cut-off score for the NINDS-CSN 5-minute protocol was identified as <9.
Limitations and Future Work
The authors acknowledge several limitations:
- Sample Size: The study's sample size of 101 patients is considered small, potentially limiting the statistical power to detect subtle differences between the MoCA and the NINDS-CSN 5-minute protocol.
- Generalizability: The PD patients had a mean duration of 5-6 years and a 60% prevalence of CI. This might limit the generalizability of findings to patients in the earlier stages of PD, who may have a lower CI prevalence.
- "Off" State Assessment: All patients were assessed in their "off" state (i.e., without medication effects). This means the results may not directly apply to patients assessed in their "on" state.
- Protocol Administration: The NINDS-CSN 5-minute protocol items were extracted from the MoCA rather than administered independently. This raises questions about whether the difficulty of individual items might differ when not part of the full MoCA.
- Expert Opinion Basis: The NINDS-CSN 5-minute protocol was initially developed based on expert opinion, not empirical evidence, and it omits certain MoCA items (like Trails B, Clock, and Serial 7s) known to be sensitive to the "subcortical profile" characteristic of PD.
Future work suggested includes:
- Conducting larger studies to confirm these findings and increase statistical power.
- Investigating the protocol's performance in early-stage PD and in "on" state assessments.
- Developing and validating a novel 5-minute screening protocol drawn from the MoCA, potentially including items more tailored to PD's cognitive profile, and administering it independently.
Summary updated